DK1849762T3 - Substituerede biphenylcarboxylsyrer og derivater deraf - Google Patents

Substituerede biphenylcarboxylsyrer og derivater deraf

Info

Publication number
DK1849762T3
DK1849762T3 DK06112938T DK06112938T DK1849762T3 DK 1849762 T3 DK1849762 T3 DK 1849762T3 DK 06112938 T DK06112938 T DK 06112938T DK 06112938 T DK06112938 T DK 06112938T DK 1849762 T3 DK1849762 T3 DK 1849762T3
Authority
DK
Denmark
Prior art keywords
derivatives
biphenylcarboxylic acids
substituted biphenylcarboxylic
substituted
acids
Prior art date
Application number
DK06112938T
Other languages
Danish (da)
English (en)
Inventor
Francis Wilson
Alison Reid
Valerie Reader
Richard John Harrison
Mihiro Sunose
Remedios Hernandez-Perni
Jeremy Major
Cyrille Boussard
Kathryn Smelt
Jess Taylor
Adeline Leformal
Andrew Cansfield
Svenja Burckhardt
Original Assignee
Cellzome Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ltd filed Critical Cellzome Ltd
Application granted granted Critical
Publication of DK1849762T3 publication Critical patent/DK1849762T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK06112938T 2006-04-21 2006-04-21 Substituerede biphenylcarboxylsyrer og derivater deraf DK1849762T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112938A EP1849762B1 (en) 2006-04-21 2006-04-21 Substituted biphenyl carboxylic acids and derivatives thereof

Publications (1)

Publication Number Publication Date
DK1849762T3 true DK1849762T3 (da) 2009-10-12

Family

ID=36688012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06112938T DK1849762T3 (da) 2006-04-21 2006-04-21 Substituerede biphenylcarboxylsyrer og derivater deraf

Country Status (35)

Country Link
US (1) US7557244B2 (pl)
EP (2) EP1849762B1 (pl)
JP (1) JP5479088B2 (pl)
KR (1) KR101542255B1 (pl)
CN (1) CN101687758B (pl)
AP (1) AP2008004656A0 (pl)
AR (1) AR060568A1 (pl)
AU (1) AU2007240335B2 (pl)
BR (1) BRPI0710656A2 (pl)
CA (1) CA2650006C (pl)
CR (2) CR10375A (pl)
CY (1) CY1109399T1 (pl)
DE (1) DE602006007810D1 (pl)
DK (1) DK1849762T3 (pl)
EA (1) EA016129B9 (pl)
ES (2) ES2328616T3 (pl)
GE (1) GEP20115269B (pl)
GT (1) GT200900120A (pl)
IL (2) IL194852A0 (pl)
MA (1) MA30475B1 (pl)
MX (1) MX2008013445A (pl)
MY (1) MY148953A (pl)
NO (1) NO20084517L (pl)
NZ (1) NZ573000A (pl)
PE (1) PE20080364A1 (pl)
PL (1) PL1849762T3 (pl)
PT (1) PT1849762E (pl)
SI (1) SI1849762T1 (pl)
SM (1) SMP200800061B (pl)
TN (1) TNSN08413A1 (pl)
TW (1) TWI399362B (pl)
UA (1) UA95952C2 (pl)
UY (1) UY30301A1 (pl)
WO (1) WO2007124394A1 (pl)
ZA (1) ZA200809856B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008312371B2 (en) * 2007-10-19 2013-06-20 Janssen Pharmaceutica, N.V. Amine linked modulators of gamma-secretase
JP5439381B2 (ja) 2007-10-19 2014-03-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ γ−セクレターゼのピペリジニル及びピペラジニル調節物質
AU2008312362A1 (en) * 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Gsm intermediates
WO2009052334A1 (en) 2007-10-19 2009-04-23 Janssen Pharmaceutica, N.V. Carbon linked modulators of y-secretase
US20110092554A1 (en) * 2007-11-19 2011-04-21 Richard Chesworth 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
AU2008345573B2 (en) 2007-12-20 2013-12-19 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
EP2488031A4 (en) * 2009-10-16 2014-07-23 Merck Sharp & Dohme DIARYL ETHER DERIVATIVES AS A NOTCH-PROOFING GAMMETRETASE INHIBITOR
US8785481B2 (en) 2010-09-29 2014-07-22 Merck Sharp & Dohme Corp. Ether benzotriazole derivatives
WO2012119035A1 (en) * 2011-03-03 2012-09-07 Treventis Corporation Anti-amyloid compounds and methods
WO2015109109A1 (en) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Fused morpholinopyrimidines and methods of use thereof
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
JP3802581B2 (ja) * 1995-03-01 2006-07-26 富山化学工業株式会社 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
DE10131899A1 (de) 2001-07-04 2003-02-27 Boehringer Ingelheim Pharma In vitro-Screening-Assay für gamma-Secretase
EP1546086A2 (en) * 2002-06-27 2005-06-29 Fujisawa Pharmaceutical Co., Ltd. Aminoalcohol derivatives
GB0305918D0 (en) * 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
WO2005110963A1 (en) * 2004-05-19 2005-11-24 Cellzome Ag (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
GB0416508D0 (en) * 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
WO2006022237A1 (ja) * 2004-08-24 2006-03-02 Kissei Pharmaceutical Co., Ltd. 脂肪肝の予防または治療剤
US8148572B2 (en) * 2005-10-06 2012-04-03 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
CA2650006C (en) 2016-08-23
AU2007240335B2 (en) 2013-05-02
DE602006007810D1 (de) 2009-08-27
GT200900120A (es) 2009-11-16
WO2007124394A1 (en) 2007-11-01
NO20084517L (no) 2009-01-13
MA30475B1 (fr) 2009-06-01
SMAP200800061A (it) 2008-11-19
CN101687758B (zh) 2014-05-14
KR101542255B1 (ko) 2015-08-06
EA200802172A1 (ru) 2009-06-30
TW200815320A (en) 2008-04-01
JP2009544573A (ja) 2009-12-17
CN101687758A (zh) 2010-03-31
MX2008013445A (es) 2009-03-10
MY148953A (en) 2013-06-14
EA016129B1 (ru) 2012-02-28
BRPI0710656A2 (pt) 2011-08-16
TWI399362B (zh) 2013-06-21
SMP200800061B (it) 2009-07-14
CA2650006A1 (en) 2007-11-01
AP2008004656A0 (en) 2008-10-31
KR20090024679A (ko) 2009-03-09
PT1849762E (pt) 2009-09-16
CR10451A (es) 2009-03-31
AU2007240335A1 (en) 2007-11-01
US7557244B2 (en) 2009-07-07
EP1849762A1 (en) 2007-10-31
EP2021314A1 (en) 2009-02-11
UA95952C2 (ru) 2011-09-26
ZA200809856B (en) 2009-06-24
IL194790A0 (en) 2009-08-03
IL194790A (en) 2012-12-31
ES2328616T3 (es) 2009-11-16
EP1849762B1 (en) 2009-07-15
EP2021314B1 (en) 2013-01-23
TNSN08413A1 (en) 2010-04-14
US20070293567A1 (en) 2007-12-20
ES2400530T3 (es) 2013-04-10
UY30301A1 (es) 2007-08-31
IL194852A0 (en) 2009-08-03
PL1849762T3 (pl) 2009-12-31
AR060568A1 (es) 2008-06-25
NZ573000A (en) 2011-11-25
EA016129B9 (ru) 2012-06-29
CY1109399T1 (el) 2014-07-02
GEP20115269B (en) 2011-08-25
CR10375A (es) 2009-02-26
SI1849762T1 (sl) 2009-12-31
PE20080364A1 (es) 2008-05-16
JP5479088B2 (ja) 2014-04-23

Similar Documents

Publication Publication Date Title
DK1849762T3 (da) Substituerede biphenylcarboxylsyrer og derivater deraf
DK1805129T3 (da) (Biphenyl-)carboxylsyrer og derivater deraf
DK2063907T3 (da) Fremgangsmåder og sammensætninger baseret på difteritoksin-interleukin-3-konjugater
DK3263589T5 (da) Peptidsekvenser og sammensætninger
NO20054709D0 (no) Sammenfoyningssystem og anvendelse av dette
DK2081955T3 (da) Metastinderivater og anvendelse deraf
DE602006008266D1 (de) Klemm- und Gelenkelement
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
DK1969391T3 (da) Tyndfilm emitter-absorber indretning og fremgangsmåde
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
ATE512135T1 (de) Spiroindolinonderivate
DK2035394T3 (da) 2-pyrazincarboxamidderivater
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf
DK2079485T3 (da) Phenylpropionamidforbindelser og anvendelsen deraf
DK2190991T3 (da) SDF-1-Bindende nucleinsyrer og anvendelsen deraf
DK2160336T3 (da) Forbindelsesmekanisme og fremgangsmåde
DK1885716T3 (da) Thiazolderivater og anvendelse deraf
DK2114393T3 (da) Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil
DK1863801T3 (da) Benzimidazolderivat og anvendelse deraf
ATE544764T1 (de) 5-hydroxymethyloxazolidin-2-onderivate
DK2158199T3 (da) Piperidinforbindelser og anvendelser deraf
DK1999403T3 (da) Multikoblingssystem og fremgangsmåde relateret dertil
ATE488493T1 (de) Biphenyl- und naphthylphenylhydroxamsäurederivate